Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes

Friday, May 13, 2022

1:50 PM – 2:10 PM

Location: Learning Lab A - AACE Learning Zone

Submitter(s)

Viral N. Shah, MD
Associate Professor
Barbara Davis Center for Diabetes, University of Colorado
Aurora, Colorado, United States

Disclosure: Dexcom (Individual(s) Involved: Self): Research Grant; Eli-Lilly (Individual(s) Involved: Self): Grant/Research Support; Insulet (Individual(s) Involved: Self): Grant/Research Support; Medscape LLC (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Grant/Research Support; Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Tandem Diabetes Care (Individual(s) Involved: Self): Research Grant

PDF Slides

Participants should be aware of the following financial/non-financial relationships:

Viral N. Shah, MD: Dexcom (Individual(s) Involved: Self): Research Grant; Eli-Lilly (Individual(s) Involved: Self): Grant/Research Support; Insulet (Individual(s) Involved: Self): Grant/Research Support; Medscape LLC (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Grant/Research Support; Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Tandem Diabetes Care (Individual(s) Involved: Self): Research Grant